All In Biotech

Drug Trial Radar · NCT00801957

Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

A Double Blind, Multicentre, Randomised, Parallel Group Study to Demonstrate the Equivalence of the Response to Vaccination of a Tacrolimus Ointment Regimen to a Steroid Ointment Regimen in Children With Moderate to Severe Atopic Dermatitis

Last checked: Nov 20, 2026Latest source record: Sep 18, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 260 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

260

Actual

Start

Mar 2003

Primary completion

Nov 2004

Study completion Nov 2004

Sponsor

Lead sponsor
Astellas Pharma IncAstellas (ALPMY)
Sponsor type
Industry
First posted
Dec 4, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Seven-month study in pediatric patients (2-11 years) with moderate to severe AD who were considered to benefit from vaccination to prevent invasive disease caused by Neisseria meningitides serogroup C.

Conditions

  • Atopic Dermatitis

Interventions

  • tacrolimus ointment 0.03%Drug

    topical application

  • hydrocortisone acetate ointment 1%Drug

    topical application

  • hydrocortisone butyrate ointment 0.1%Drug

    topical application

  • MeningitecBiological

    im injection

  • AC VAXBiological

    im injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of patients with serum bactericidal antibody titer of ≥ 8Time frame: 5 weeks

Locations

36 sites in 8 countries. Site status is shown where the registry gives one.

  • Site not named

    Kogarah, New South Wales, Australia

  • Site not named

    St Leonards, New South Wales, Australia

  • Site not named

    Benowa, Queensland, Australia

  • Site not named

    Carina Heights, Queensland, Australia

  • Site not named

    Herston, Queensland, Australia

  • Site not named

    North Adelaide, South Australia, Australia

  • Site not named

    Carlton, Victoria, Australia

  • Site not named

    Parkville, Victoria, Australia

  • Site not named

    Fremantle, Western Australia, Australia

  • Site not named

    Leuven, Belgium

  • Site not named

    Bretten, Germany

  • Site not named

    Ettenheim, Germany

  • Site not named

    Gersfeld, Germany

  • Site not named

    Kehl, Germany

  • Site not named

    Tettnang, Germany

  • Site not named

    Budapest, Hungary

  • Site not named

    Debrecen, Hungary

  • Site not named

    Pécs, Hungary

  • Site not named

    Szeged, Hungary

  • Site not named

    Kopavogur, Iceland

  • Site not named

    Saint Julians, Malta

  • Site not named

    Karpacz, Poland

  • Site not named

    Krakow, Poland

  • Site not named

    Lodz, Poland

  • Site not named

    Lodz, Poland

  • Site not named

    Opole, Poland

  • Site not named

    Poznan, Poland

  • Site not named

    Rabka-Zdrój, Poland

  • Site not named

    Warsaw, Poland

  • Site not named

    Warsaw, Poland

  • Site not named

    Wroclaw, Poland

  • Site not named

    Wroclaw, Poland

  • Site not named

    Zabrze, Poland

  • Site not named

    Zgierz, Poland

  • Site not named

    Lisbon, Portugal

  • Site not named

    Porto, Portugal

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.